Search results for " pharmaceutical"
Article
Elucidating Biosimilars Characterization
Rather than requiring full clinical trials, generic drug manufacturers are requested to demonstrate pharmaceutical equivalence to show that their medicine contains the same active pharmaceutical ingre…
Article
Biosimilars Development and Supply: How Complex Can the Process Be?
For approximately every 5000 to 10,000 pharmaceutical and biologic discoveries in preclinical testing, only one is eventually commercialized (4). An even smaller number of these medicines are biologic…
Article
HT Multi-Product Liquid Chromatography for Characterization of Monoclonal Antibodies
Of the classes of immunoglobulins, IgG1 is the most commonly used for pharmaceutical and biomedical purposes.2
In recent years, increased understanding of disease and advances in drug discover…
Resource
International Conference on Harmonization
The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmace…
Article
A Closer Look at Affinity Ligands
As an example, much engineering has recently gone into modifying the Protein A ligand to ensure it can withstand the stringent cleaning and sanitization procedures required for use in a pharmaceutical…
Article
Balancing AAVs Versus LLVs
Knowledge of adeno-associated variant's infection pathway is based on only a few serotypes. The prevailing understanding is that serotypes bind to different, or have differential affiniti…
Article
Accelerating time to market through process innovation
During this workshop you will hear from industry experts from Cytiva, Chugai Pharmaceuticals and NorthX Biologics on process innovations to accelerate your time to market.
Topics include:
- Next…
Article
Optimization of a two-step purification method for bispecific antibodies
Alligator Bioscience AB develops antibody-based pharmaceuticals for cancer treatment, specializing in mono- and bispecific antibodies for tumor-directed immunotherapies. The company is active in the e…
Article
Top Process Development Trends for 2022 and a Look into 2023
These treatments illustrate a sea change within the pharmaceutical industry—a rising requirement to handle complex molecules for emerging therapies. In parallel, brought on by the obvious commercial s…
Article
Increasing mRNA capabilities and capacity for growing market needs
The rapid development of innovative vaccines allowed for the pharmaceutical industry to deliver its first tools in the fight against the COVID-19 pandemic.
READ FULL ARTICLE >>